as on November 14, 2025 at 2:29 am IST
Day's Low
Day's High
1.46%
Downside
4.90%
Upside
52 Week's Low
52 Week's High
51.45%
Downside
57.12%
Upside
Check Viking Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.6B
EPS (TTM)
-2.6102
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
-0.03
EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-29.23%
Compare market cap, revenue, PE, and other key metrics of Viking Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.6B | 569.62% | NA | 0.00% | |
| BUY | $41.5B | 437.88% | -16.34 | -264.83% | |
| BUY | $59.7B | 234.1% | 1412.34 | 1.36% | |
| BUY | $108.9B | 92.53% | 30.21 | 31.35% | |
| BUY | $70.9B | 20.35% | 16.18 | 32.13% |
The Viking Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Viking Therapeutics, Inc. investment value today
Current value as on today
₹75,915
Returns
Returns from Viking Therapeutics, Inc. Stock
Dollar Returns*
₹5,138 (+5.14%)
Based on 17 analysts
94.12%
Buy
5.88%
Hold
0.00%
Sell
Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Viking Therapeutics, Inc.. Average target price of $93.33
Get share price movements and forecasts by analysts on Viking Therapeutics, Inc..
What analysts predicted
58.24%UPSIDE
Target Price
$93.33
Current Price
$38.97
Analyzed by
17 Analysts
Target
$93.33
Viking Therapeutics, Inc. target price $93.33, a slight upside of 58.24% compared to current price of $38.97. According to 17 analysts rating.
Investment in Viking Therapeutics, Inc. Shares on INDmoney has dropped by -14.80% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Viking Therapeutics, Inc. Stock has increased by 94% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:94% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 November
Wed, 03:45 PM
-Viking Therapeutics shares rose 44.9% in October, driven by positive news on lead drug candidate VK2735.
Wed, 08:31 PM
-Stanley Druckenmiller's family office acquired 549,000 shares of VKTX, now up 36%, signaling a bullish trend.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, VKTX stock has moved up by 9.4%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 175.3% return, outperforming this stock by 201.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 919.3% return, outperforming this stock by 43.7%
| Organisation | Viking Therapeutics, Inc. |
| Headquarters | 9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Dr. Brian Lian Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Marianne Mancini | Chief Operating Officer |
Mr. Michael Morneau | Vice President of Finance & Administration |
Dr. Geoffrey E. Barker Ph.D. | Chief Development Officer |
Dr. Brian Lian Ph.D. | President, CEO & Director |
Mr. Gregory S. Zante CPA, CPA | Chief Financial Officer |
Viking Therapeutics, Inc. share price today is $38.97 as on at the close of the market. Viking Therapeutics, Inc. share today touched a day high of $40.88 and a low of $38.4.
Viking Therapeutics, Inc. share touched a 52 week high of $61.23 on and a 52 week low of $18.92 on . Viking Therapeutics, Inc. stock price today i.e. is closed at $38.97,which is 36.35% down from its 52 week high and 105.97% up from its 52 week low.
Viking Therapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Viking Therapeutics, Inc. (VKTX) shares with as little as ₹88.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.52 in Viking Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Viking Therapeutics, Inc. share’s latest price of $38.97 as on November 14, 2025 at 2:29 am IST, you will get 0.2566 shares of Viking Therapeutics, Inc.. Learn more about
fractional shares .
Viking Therapeutics, Inc. stock has given 569.62% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?